CVS Health (CVS) Expected to Beat Earnings Estimates: Should You Buy?

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for CVS Health despite higher revenues, with a focus on how actual results will compare to estimates [1] Earnings Expectations - CVS Health is expected to report quarterly earnings of $0.99 per share, reflecting a year-over-year decrease of 16.8% [3] - Revenue projections stand at $103.13 billion, indicating a 5.5% increase from the previous year [3] Estimate Revisions - The consensus EPS estimate has been revised down by 0.1% over the last 30 days, indicating a reassessment by analysts [4] - The Most Accurate Estimate for CVS Health is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +0.38% [12] Earnings Surprise Prediction - A positive Earnings ESP is a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10] - CVS Health currently holds a Zacks Rank of 3, suggesting a likelihood of beating the consensus EPS estimate [12] Historical Performance - CVS Health has consistently beaten consensus EPS estimates, achieving this in the last four quarters [14] - In the last reported quarter, CVS Health exceeded expectations by delivering earnings of $1.60 per share against an expected $1.36, resulting in a surprise of +17.65% [13] Market Reaction - The stock price may increase if earnings exceed expectations, while a miss could lead to a decline [2] - Other factors beyond earnings results may also influence stock movement, highlighting the complexity of market reactions [15]